Thomas G - Search Results

1

Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.

Nofech-Mozes S, Ghorab Z, Ismiil N, Ackerman I, Thomas G, Barbera L, Covens A, Khalifa MA. Nofech-Mozes S, et al. Among authors: thomas g. Am J Clin Pathol. 2008 Jan;129(1):110-4. doi: 10.1309/UDYANQ6XTK6UUTXQ. Am J Clin Pathol. 2008. PMID: 18089496

2

Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma.

Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A, Khalifa MA. Nofech-Mozes S, et al. Among authors: thomas g. Am J Clin Pathol. 2008 Jun;129(6):912-7. doi: 10.1309/CP3HGX7H753QQU8T. Am J Clin Pathol. 2008. PMID: 18480008

3

Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.

Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA. Ismiil ND, et al. Among authors: thomas g. Int J Gynecol Pathol. 2007 Jul;26(3):278-83. doi: 10.1097/01.pgp.0000235064.93182.ec. Int J Gynecol Pathol. 2007. PMID: 17581412

4

Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.

Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA. Ismiil N, et al. Among authors: thomas g. Ann Diagn Pathol. 2007 Aug;11(4):252-7. doi: 10.1016/j.anndiagpath.2006.08.011. Ann Diagn Pathol. 2007. PMID: 17630108

5

Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: A population-based cohort study.

Gien LT, Sutradhar R, Thomas G, Covens A, Elit L, Rakovitch E, Fyles A, Khalifa MA, Liu Y, Barbera L. Gien LT, et al. Among authors: thomas g. Gynecol Oncol. 2015 Dec;139(3):465-70. doi: 10.1016/j.ygyno.2015.09.086. Epub 2015 Oct 23. Gynecol Oncol. 2015. PMID: 26483007

6

Venous thromboembolism in cervical cancer.

Barbera L, Thomas G. Barbera L, et al. Among authors: thomas g. Lancet Oncol. 2008 Jan;9(1):54-60. doi: 10.1016/S1470-2045(07)70409-6. Lancet Oncol. 2008. PMID: 18177817 Review.

7

Treating vulvar cancer in the new millennium: are patients receiving optimal care?

Barbera L, Thomas G, Elit L, Covens A, Fyles A, Osborne R, Yun L. Barbera L, et al. Among authors: thomas g. Gynecol Oncol. 2008 Apr;109(1):71-5. doi: 10.1016/j.ygyno.2007.12.015. Epub 2008 Jan 29. Gynecol Oncol. 2008. PMID: 18234304

8

Management of early and locally advanced cervical cancer.

Barbera L, Thomas G. Barbera L, et al. Among authors: thomas g. Semin Oncol. 2009 Apr;36(2):155-69. doi: 10.1053/j.seminoncol.2008.12.007. Semin Oncol. 2009. PMID: 19332250 Review.

9

Erythropoiesis stimulating agents, thrombosis and cancer.

Barbera L, Thomas G. Barbera L, et al. Among authors: thomas g. Radiother Oncol. 2010 Jun;95(3):269-76. doi: 10.1016/j.radonc.2010.02.008. Epub 2010 Mar 8. Radiother Oncol. 2010. PMID: 20219259 Review.

10

Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.

Forrest JL, Ackerman I, Barbera L, Barnes EA, Davidson M, Kiss A, Thomas G. Forrest JL, et al. Among authors: thomas g. Int J Gynecol Cancer. 2010 Aug;20(6):1074-8. doi: 10.1111/IGC.0b013e3181e6f321. Int J Gynecol Cancer. 2010. PMID: 20683420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,137 results

Search Page

Filters